Dennis Podlesak

SNDX

Dennis Podlesak serves as Director at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$197.1K

Total Sells

2 trades

$2.77M

Net Position

Net Seller

$2.58M

Companies Traded

SNDX

Active Period

Apr 2021 – Aug 2025

3 total trades

Most Recent

Sell SNDX

Aug 14, 2025 · $875.1K

Dennis Podlesak's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

1 · $197.1K

Sells

2 · $2.77M

Total Shares Bought

13,967

Total Shares Sold

136,415

SNDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 14, 2025	Sell	57,600	$15.19	$875.1K	0
Sep 16, 2022	Sell	78,815	$24.08	$1.90M	75,763
Apr 22, 2021	Buy	13,967	$14.11	$197.1K	43,300

Related Insiders

Keith A. Goldan

officer: Chief Financial Officer

SNDXSell · Feb 10, 2026

Michael A Metzger

director, officer: Chief Executive Officer

SNDXSell · Feb 10, 2026

Martin H. Huber Jr.

Director

SNDXBuy · May 19, 2025

Keith Katkin

Director

SNDXBuy · May 19, 2025

Nicholas A.J. Botwood

Head of R&D, CMO

SNDXBuy · May 16, 2025

Explore More Insider Trading Data

SNDX Insider Trading Activity

View all insider trades at Syndax Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity